Full-Time

Territory Manager

Field Based

Confirmed live in the last 24 hours

Insulet Corporation

Insulet Corporation

1,001-5,000 employees

Biotechnology
Healthcare

Compensation Overview

$165k - $180kAnnually

Senior

Evansville, IN, USA

This position requires field-based working arrangements (travel within assigned territory required).

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Salesforce
Marketing
Business Strategy
Data Analysis

You match the following Insulet Corporation's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Ability to set, communicate, and execute territory business strategy
  • Ability to execute sales and marketing plan
  • Excellent communication skills, both oral and written
  • Strong influencing and collaboration skills with the ability to build and nurture relationships
  • Team-oriented with proven ability to orchestrate activities in a collaborative setting
  • Ability to solve complex problems and take appropriate action
  • Proficiency with technology (both large data systems as well as personal devices, such as insulin pumps and continuous glucose monitors)
Responsibilities
  • Develop and lead the territory’s business strategy, aligning territory partners around clear, actionable plans to achieve and exceed business goals
  • Collaborate with territory partners to co-create efficient routing strategies and orchestrate a seamless, results-driven customer engagement process
  • Take full ownership of the patient onboarding process, ensuring its successful completion either through direct efforts or by effectively coordinating with teammates
  • Own and exceed sales targets while driving market share growth within the assigned geographic area through proactive and strategic business management
  • Execute all field sales initiatives with entrepreneurial precision, ensuring they align with both company standards and innovative promotional practices that maximize impact
  • Leverage a consultative approach when sharing industry, disease, and product knowledge that fosters trust with providers and positions you as an expert who adds value beyond the product
  • Build and use knowledge of Type 1 and Type 2 diabetes to sell with clinical credibility. Build contacts within the diabetes community by attending local events, participating in fund raisers, and connecting with influencers
  • Present Insulet products and differentiate them from competitive products, offering in-depth knowledge and strategic insights to address customer needs
  • Analyze problems, identify root causes, and implement solutions that resolve provider and patient issues
  • Collaborate with internal stakeholders in delivering high-quality customer onboarding and training, ensuring a patient-centric approach
  • Cultivate and strengthen relationships with the entire office (HCPs, administrative staff, etc.), positioning yourself as a trusted partner in driving positive outcomes for their business and their patients
  • Collaborate with internal colleagues across functions, fostering a culture of shared success, driving productivity, and achieving common goals through effective teamwork
  • Leverage diverse data sources to drive informed business decisions and shape strategic actions for territory performance
  • Lead territory prioritization efforts, ensuring resources are focused on and aligned to the highest impact opportunities
  • Maintain and update data systems, such as Salesforce, to capture territory-specific insights that enhance business outcomes
  • Conduct administrative responsibilities, managing operations while adhering to budgetary guidelines
Desired Qualifications
  • Bachelor’s degree (strongly preferred) with a minimum of 5 years of sales experience and demonstrated success in B2B or a related field (healthcare, pharmaceuticals, medical device, or diabetes); Associate degree (minimally required)
  • Possess a strong network of established professional relationships with endocrinologists and primary care providers specializing in diabetes (preferred)

Company Size

1,001-5,000

Company Stage

IPO

Total Funding

$134.6M

Headquarters

Acton, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Omnipod 5's expansion in Europe boosts Insulet's international market presence.
  • New manufacturing facility in Malaysia supports increased production capacity and job creation.
  • Growing global insulin pump market offers significant revenue opportunities for Insulet.

What critics are saying

  • Emerging competitors like Tandem Diabetes Care threaten Insulet's market share.
  • Geopolitical tensions in Malaysia could disrupt Insulet's supply chain.
  • Technical challenges with sensor integration may delay Omnipod 5 product rollouts.

What makes Insulet Corporation unique

  • Insulet's Omnipod 5 offers tubeless insulin delivery, a unique market feature.
  • Integration with Dexcom G7 and FreeStyle Libre 2 Plus enhances Omnipod 5's functionality.
  • Insulet's proprietary technology is protected by a recent $452 million trade secret victory.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

-2%
MPO Magazine
Jan 14th, 2025
Insulet Rolls Out Omnipod 5 in Five More European Countries

Also in June 2024, Insulet launched Omnipod 5 with the Dexcom G7 CGM.

Bloomberg Law
Dec 5th, 2024
Insulet Wins $452 Million in Insulin Pump Trade Secrets Trial

EOFlow Co. Ltd. must pay Insulet Corp. $452 million for stealing trade secrets related to its insulin pumps, a Massachusetts federal jury ruled.

MPO Magazine
Dec 5th, 2024
Insulet Wins $452 Million Trade Secret Victory Against EOFlow

Insulet was awarded $170 million in compensatory damages from EOFlow and a further $282 million in exemplary damages for willful and malicious misappropriation.

Stock Titan
Oct 29th, 2024
Omnipod(R) 5 App for iPhone(R) Now Fully Available in the United States

ACTON, Mass.-(BUSINESS WIRE)- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod(R) brand of products, today announced the full market release of the Omnipod 5 App for iPhone(R) in the U.S.

Fierce Pharma
Aug 15th, 2024
Insulet unveils $200M insulin delivery device production site in Malaysia

Insulet expects to eventually hire more than 1,000 employees at the site in the next few years, it said in an August 14 press release.